Della Porta Matteo Giovanni
Della Porta Matteo Giovanni
Professor of Hematology, Humanitas University, Milan - Italy
Verified email at
Cited by
Cited by
Clinical and biological implications of driver mutations in myelodysplastic syndromes
E Papaemmanuil, M Gerstung, L Malcovati, S Tauro, G Gundem, ...
Blood, The Journal of the American Society of Hematology 122 (22), 3616-3627, 2013
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ...
New England Journal of Medicine 365 (15), 1384-1395, 2011
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.
L Malcovati, U Germing, A Kuendgen, MG Della Porta, C Pascutto, ...
Journal of clinical oncology 25 (23), 3503-3510, 2007
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making
L Malcovati, MGD Porta, C Pascutto, R Invernizzi, M Boni, E Travaglino, ...
Journal of Clinical Oncology 23 (30), 7594-7603, 2005
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
L Malcovati, E Hellström-Lindberg, D Bowen, L Adès, J Cermak, ...
Blood, The Journal of the American Society of Hematology 122 (17), 2943-2964, 2013
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
L Malcovati, E Papaemmanuil, DT Bowen, J Boultwood, MG Della Porta, ...
Blood, The Journal of the American Society of Hematology 118 (24), 6239-6246, 2011
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
F Passamonti, C Cattaneo, L Arcaini, R Bruna, M Cavo, F Merli, ...
The Lancet Haematology 7 (10), e737-e745, 2020
CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure
M Valgimigli, GM Rigolin, A Fucili, MD Porta, O Soukhomovskaia, ...
Circulation 110 (10), 1209-1212, 2004
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
L Malcovati, M Karimi, E Papaemmanuil, I Ambaglio, M Jädersten, ...
Blood, The Journal of the American Society of Hematology 126 (2), 233-241, 2015
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ...
Nature medicine 26 (10), 1549-1556, 2020
The genetic basis of myelodysplasia and its clinical relevance
M Cazzola, MG Della Porta, L Malcovati
Blood, The Journal of the American Society of Hematology 122 (25), 4021-4034, 2013
Molecular international prognostic scoring system for myelodysplastic syndromes
E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ...
NEJM evidence 1 (7), EVIDoa2200008, 2022
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
L Malcovati, MG Della Porta, C Strupp, I Ambaglio, A Kuendgen, ...
Haematologica 96 (10), 1433, 2011
Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome
M Jadersten, L Malcovati, I Dybedal, M Giovanni Della Porta, R Invernizzi, ...
Journal of Clinical Oncology 26 (21), 3607-3613, 2008
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
E Such, U Germing, L Malcovati, J Cervera, A Kuendgen, MG Della Porta, ...
Blood, The Journal of the American Society of Hematology 121 (15), 3005-3015, 2013
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
A Pellagatti, M Cazzola, A Giagounidis, J Perry, L Malcovati, ...
Leukemia 24 (4), 756-764, 2010
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
J Boultwood, J Perry, A Pellagatti, M Fernandez-Mercado, ...
Leukemia 24 (5), 1062-1065, 2010
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative …
F Passamonti, E Rumi, D Pietra, MGD Porta, E Boveri, C Pascutto, ...
Blood 107 (9), 3676-3682, 2006
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes
MG Della Porta, L Malcovati, E Boveri, E Travaglino, D Pietra, C Pascutto, ...
Journal of clinical oncology 27 (5), 754-762, 2009
The system can't perform the operation now. Try again later.
Articles 1–20